EDGAR Filing Documents for 0001104659-17-040024

Form CORRESP - Correspondence:

SEC Accession No. 0001104659-17-040024

Filing Date

2017-06-19

Accepted

2017-06-19 06:16:17

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	CORRESP	17044
2	GRAPHIC	g114796bgi001.gif	GRAPHIC	1275
	Complete submission text file	0001104659-17-040024.txt		19854

Mailing Address 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC 27713

Business Address 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC 27713 919-806-4487

Dova Pharmaceuticals, Inc. (Filer) CIK: 0001685071 (see all company filings)

IRS No.: 813858961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations